David L Murray

Title: David L. Murray: Innovator in Ophthalmic Pharmaceuticals

Introduction

David L. Murray is a notable inventor based in Mission Viejo, California. He has made significant contributions to the field of ophthalmic pharmaceuticals, particularly in the treatment of glaucoma. His innovative work focuses on lowering intraocular pressure, which is crucial for patients suffering from this condition.

Latest Patents

David L. Murray holds a patent for the "Topical ophthalmic use of Prazosin." This patent describes an ophthalmic composition that includes Prazosin or a pharmaceutically acceptable salt thereof, combined with a topically administrable ophthalmic pharmaceutical carrier. The composition is designed to effectively lower intraocular pressure in the eye, addressing a critical need in glaucoma treatment.

Career Highlights

Murray is associated with Allergan Pharmaceuticals, a leading company in the field of eye care. His work at Allergan has allowed him to focus on developing innovative solutions for ocular health. With a patent portfolio that includes 1 patent, he has established himself as a key player in ophthalmic research.

Collaborations

David L. Murray has collaborated with various professionals in the field, including his coworker Barry R. Smith. These collaborations have contributed to the advancement of ophthalmic treatments and have fostered a culture of innovation within the company.

Conclusion

David L. Murray's contributions to ophthalmic pharmaceuticals highlight his commitment to improving patient care in the field of eye health. His innovative patent for the topical use of Prazosin exemplifies the importance of research and development in treating glaucoma.